Table 2.

Lesional characteristics on [¹⁸F]fluciclatide imaging

Pt no.	Lesion location	SUV60,mean (preRx)	SUV60,max (preRx)	Lesional response	Percentage change SUV60,ave	Percentage change SUV60,max
1A	Gastrosplenic/peritoneal deposit	4.42	6.97	PR	− 33.98	− 29.65
2A	Right paracolic gutter	1.83	3.13	PR	− 6.58	9.74
2B	Mesorectal nodule	0.91	1.9	SD	7.73	− 6.32
2C	Right obturator node	2.00	2.48	PR	− 10.00	− 0.40
2D	Para-aortic node	3.13	4.44	CR	− 3.35	22.86
3A	Vaginal vault mass	4.55	8.23	PR	− 32.67	− 18.72
3B	Left obturator node	3.99	5.88	PR	− 39.92	− 31.04
3C	Left common iliac node*	3.73	5.38	CR	–	–
4A	Right obturator node	4.37	6.45	PR	− 15.79	− 14.96
5A	Anterior pelvic mass	1.26	4.62	SD	− 25.89	3.03
5B	Posterior pelvic mass	0.36	4.25	PR	61.97	3.29
6A	Peritoneal deposit	2.52	4.57	SD	− 13.92	− 9.63
6B	Subcapsular deposit	2.67	4.06	SD	− 1.50	− 5.55
6C	Para-aortic node	2.23	3.36	SD	1.57	0
8A	Right lower lobe pulmonary metastasis	1.18	1.42	CR	− 37.71	− 38.87
8B	Splenic lesion	2.78	3.52	SD	− 21.62	8.95
8C	Liver lesion	2.99	3.34	SD	− 54.92	− 39.43
9A	Left adnexal mass	1.56	3.14	NE	− 9.62	− 7.97
9B	Peritoneal lesion	1.25	1.93	NE	− 9.24	32.64
10A	Splenic lesion	3.46	4.32	PR	− 64.98	− 18.54
10B	Para-aortic node	2.87	6.99	PR	− 48.52	− 51.61
13A	Pelvic mass	3.62	5.99	PD	− 18.92	1.58
14A	Peritoneal mass	3.11	5.28	SD	− 55.47	− 20.66
103A	Vaginal mass	1.21	4.03	PR	20.66	4.96
104A	Pulmonary mass	2.39	3.38	PR	− 52.61	− 20.15
104B	Nodal mass	1.43	3.09	PR	− 44.76	3.55
104C	Left upper lobe pulmonary metastasis	1.97	2.96	PR	− 36.54	− 34.46
104D	Apical nodal mass	1.89	2.79	PR	− 27.85	− 26.52

CR complete response, PR partial response, SD stable disease, NE not evaluable

*Lesion not seen on repeat PET imaging